Scholar Rock Holding Corp (SRRK)
26.87
-0.63
(-2.29%)
USD |
NASDAQ |
Nov 15, 12:53
Scholar Rock Free Cash Flow: -168.65M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -168.65M |
| March 31, 2024 | -152.02M |
| December 31, 2023 | -145.30M |
| September 30, 2023 | -136.97M |
| June 30, 2023 | -131.21M |
| March 31, 2023 | -133.83M |
| December 31, 2022 | -133.76M |
| September 30, 2022 | -137.73M |
| June 30, 2022 | -148.61M |
| March 31, 2022 | -146.19M |
| December 31, 2021 | -132.04M |
| September 30, 2021 | -120.70M |
| June 30, 2021 | -108.54M |
| March 31, 2021 | -95.64M |
| Date | Value |
|---|---|
| December 31, 2020 | -64.36M |
| September 30, 2020 | -60.24M |
| June 30, 2020 | -50.49M |
| March 31, 2020 | -47.59M |
| December 31, 2019 | -66.23M |
| September 30, 2019 | 5.70M |
| June 30, 2019 | 11.57M |
| March 31, 2019 | 16.93M |
| December 31, 2018 | 23.08M |
| September 30, 2018 | -37.49M |
| June 30, 2018 | -33.66M |
| March 31, 2018 | -27.45M |
| December 31, 2017 | -22.10M |
Free Cash Flow Range, Past 5 Years
-168.65M
Minimum
Jun 2024
-47.59M
Maximum
Mar 2020
-114.74M
Average
-132.04M
Median
Dec 2021
Free Cash Flow Benchmarks
| Cytokinetics Inc | -407.05M |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Ocugen Inc | -54.47M |
| Mirum Pharmaceuticals Inc | -39.22M |
| NeuroBo Pharmaceuticals Inc | -22.69M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -49.20M |
| Cash from Investing (Quarterly) | 50.62M |
| Cash from Financing (Quarterly) | -0.033M |
| Free Cash Flow Per Share (Quarterly) | -0.5084 |
| Free Cash Flow Yield | -6.85% |